These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18437778)

  • 41. [Two cytological methods for screening for cervical cancer].
    Kirschner B; Simonsen K; Junge J
    Ugeskr Laeger; 2008 May; 170(22):1933-7. PubMed ID: 18513478
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Should cervical smears be taken at a postnatal visit?
    Leahy M; Farah N; Bolger N; O'Leary JJ; Turner MJ
    Ir Med J; 2006 Sep; 99(8):244-5. PubMed ID: 17120611
    [No Abstract]   [Full Text] [Related]  

  • 43. [Screening for cancer of the uterine cervix].
    Lunde KJ
    Tidsskr Nor Laegeforen; 1984 May; 104(14):996-7. PubMed ID: 6463994
    [No Abstract]   [Full Text] [Related]  

  • 44. Screening the hard to reach: improving morbidity and mortality from cervical cancer in New Zealand.
    Sykes P; Sadler L; Priest P
    N Z Med J; 2008 Jul; 121(1277):5-7. PubMed ID: 18677325
    [No Abstract]   [Full Text] [Related]  

  • 45. Cervical cancer screening in the early post vaccine era.
    Waxman AG
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):537-48; vii. PubMed ID: 19061815
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tracking cancer screening progress.
    Hanson K; Bondurant E
    NCSL Legisbrief; 2009 Mar; 17(17):1-2. PubMed ID: 19301481
    [No Abstract]   [Full Text] [Related]  

  • 47. [HPV test for quality control of gynecologic cytological tests].
    Wilander E; Wikström I
    Lakartidningen; 2008 Nov 26-Dec 9; 105(48-49):3560, 3564. PubMed ID: 19133586
    [No Abstract]   [Full Text] [Related]  

  • 48. Mass population screening for cervix cancer.
    Christopherson WM
    Tumori; 1976; 62(3):297-301. PubMed ID: 1014125
    [No Abstract]   [Full Text] [Related]  

  • 49. Overview of the cytology laboratory: specimen processing through diagnosis.
    Joste N
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):549-63; viii. PubMed ID: 19061816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
    Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
    Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cervical cancer screening: a new tool to do one's best or doing one's best with a new tool?].
    Lavoué V; Levêque J
    Gynecol Obstet Fertil; 2009; 37(7-8):680-2. PubMed ID: 19574078
    [No Abstract]   [Full Text] [Related]  

  • 52. Early detection of precursors of cervical cancer with cervical cytology and visual inspection of cervix with acetic Acid.
    Dhaubhadel P; Vaidya A; Choudhary P
    JNMA J Nepal Med Assoc; 2008; 47(170):71-6. PubMed ID: 18709035
    [TBL] [Abstract][Full Text] [Related]  

  • 53. THE CONTROL OF CANCER OF THE UTERINE CERVIX.
    FREELING P
    J Coll Gen Pract; 1964 May; 7(3):359-78. PubMed ID: 14142937
    [No Abstract]   [Full Text] [Related]  

  • 54. Cervical cancer 1: an overview of screening and diagnosis.
    Jefferies H
    Nurs Times; 2008 Nov 4-10; 104(44):26-7. PubMed ID: 19014130
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cervical cancer and cytology screening in New Zealand.
    Johannesson G; Day NE
    Br J Obstet Gynaecol; 1979 Aug; 86(8):671-2. PubMed ID: 497140
    [No Abstract]   [Full Text] [Related]  

  • 56. [CYTOLOGIC STUDIES IN THE DIAGNOSIS OF CANCER OF THE UTERINE CERVIX DURING PREVENTIVE MASS SCREENINGS].
    UGRIUMOVA RP
    Akush Ginekol (Mosk); 1965; 41():99-101. PubMed ID: 14307277
    [No Abstract]   [Full Text] [Related]  

  • 57. [Cervix cancer screening failure in the county of Funen in spite of 25-year experiences].
    Bagger P
    Ugeskr Laeger; 2006 Sep; 168(37):3145; author reply 3145. PubMed ID: 17009417
    [No Abstract]   [Full Text] [Related]  

  • 58. The cervical smear pattern in patients with chronic pelvic inflammatory disease.
    Abdul MA; Shittu SO; Randawa JA; Shehu MS
    Niger J Clin Pract; 2009 Sep; 12(3):289-93. PubMed ID: 19803028
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytologically diagnosed Gardnerella vaginalis infection and cervical (pre)neoplasia as established in population-based cervical screening.
    Klomp JM; Boon ME; Van Haaften M; Heintz AP
    Am J Obstet Gynecol; 2008 Nov; 199(5):480.e1-5. PubMed ID: 18565490
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Are levels in cervical specimens necessary?
    Heatley MK
    J Clin Pathol; 2009 Mar; 62(3):287. PubMed ID: 19251960
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.